Edward Nesbitt Wilson, PhD
Affiliations: | 2011-2016 | Pharmacology and Therapeutics | McGill University, Montreal, QC, Canada |
2016- | Neurology | Stanford University, Palo Alto, CA |
Area:
Alzheimer's disease,Google:
"Edward Wilson"Cross-listing: Neurotree - Alzheimer's Tree
Parents
Sign in to add mentorKevin Duffy | research assistant | 2007-2008 | Dalhousie University (Neurotree) |
A Claudio Cuello | grad student | 2011-2016 | McGill University School of Medicine (Neurotree) |
Katrin Andreasson | post-doc | 2016- | Stanford University Medical School (Neurotree) |
Collaborators
Sign in to add collaboratorYogita Chudasama | collaborator | 2010-2016 | McGill (Neurotree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wilson EN, Wang C, Swarovski MS, et al. (2024) TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models. Nature Neuroscience |
Plastini MJ, Abdelnour C, Young CB, et al. (2024) Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra. Annals of Clinical and Translational Neurology |
Cruchaga C, Ali M, Shen Y, et al. (2024) Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease. Research Square |
Abiose O, Rutledge J, Moran-Losada P, et al. (2023) Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Oh HS, Rutledge J, Nachun D, et al. (2023) Organ aging signatures in the plasma proteome track health and disease. Nature. 624: 164-172 |
Chaney AM, Cropper HC, Jain P, et al. (2023) PET imaging of TREM1 identifies CNS-infiltrating myeloid cells in a mouse model of multiple sclerosis. Science Translational Medicine. 15: eabm6267 |
Cruchaga C, Western D, Timsina J, et al. (2023) Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer's disease. Research Square |
Shuken SR, Rutledge J, Iram T, et al. (2023) Publisher Correction: Limited proteolysis-mass spectrometry reveals aging-associated changes in cerebrospinal fluid protein abundances and structures. Nature Aging. 2: 455 |
Shuken SR, Rutledge J, Iram T, et al. (2022) Limited Proteolysis-Mass Spectrometry Reveals Aging-Associated Changes in Cerebrospinal Fluid Protein Abundances and Structures. Nature Aging. 2: 379-388 |
Wilson EN, Young CB, Ramos Benitez J, et al. (2022) Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease. Alzheimer's Research & Therapy. 14: 172 |